Patent · US Active

Cross-linkers and their uses

US10494431B2 · kind B2 · utility

1Cited by

19References

8Claims

0Family size

Assignee

IMMUNOGEN, INC. · US

Inventors

Ravi V. J. Chari · Newton, US
Robert Yongxin Zhao · Lexington, US
Yelena Kovtun · Stow, US
Rajeeva Singh · Framingham, US
Wayne C. Widdison · Belmont, US

Key dates

Filing date	Mar 5, 2018
Grant date	Dec 3, 2019
Priority date	—
Expiry date	Mar 5, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Charged or pro-charged cross-linking moieties and conjugates of cell binding agents and drugs comprising the charged or pro-charged cross-linking moieties and method of making the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.